The European Medicines Agency EMA has beforehand advisable EU member states to approve the vaccine. EMA can solely give a suggestion to EU member states. The formal determination on a suggestion rests with the European Commission.
Formally, it’s the Public Health Authority (FHM) that makes selections about use in Sweden, and it is usually FHM that recommends which teams ought to be vaccinated, writes the Medical Products Agency in a press launch.
The Imvanex vaccine has been authorised within the EU since 2013.